Updated indications for the recombinant, adjuvanted RSV vaccine

Description

In this Product Explainer Cardiologist Prof Andrew Sindone provides an update on a recombinant, adjuvanted respiratory syncytial virus (RSV) vaccine.

This educational video was developed by Healthed in collaboration with and with funding from GSK.
Views of the speaker are their own and do not necessarily reflect that of GSK. GSK recommends usage in accordance with the Product Information.
PM-AU-RSA-WCNT-250023. Date of approval: May 2025.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Jane Elliott AM & Prof Rod Baber AM

Dr Jane Elliott AM & Prof Rod Baber AM

Non-Hormonal Options for Menopausal Symptoms

Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

Holter Monitoring in GP – Cases and Practical Tips

Dr Rupert Hinds

Dr Rupert Hinds

Management of Constipation in Children

A/Prof Greg Katsoulotos

A/Prof Greg Katsoulotos

Inhaler Devices – Common User Errors

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Andrew Sindone AM

expert

Prof Andrew Sindone AM

Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital; Head, Department of Cardiology, Ryde Hospital

Date published: 27 May 2025